Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Share-based Compensation: 2018-2025

Historic Share-based Compensation for Evolus (EOLS) over the last 8 years, with Sep 2025 value amounting to $5.1 million.

  • Evolus' Share-based Compensation fell 1.63% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.7 million, marking a year-over-year increase of 6.06%. This contributed to the annual value of $22.3 million for FY2024, which is 35.22% up from last year.
  • According to the latest figures from Q3 2025, Evolus' Share-based Compensation is $5.1 million, which was up 14.42% from $4.5 million recorded in Q2 2025.
  • In the past 5 years, Evolus' Share-based Compensation registered a high of $6.2 million during Q4 2024, and its lowest value of $1.6 million during Q1 2021.
  • Over the past 3 years, Evolus' median Share-based Compensation value was $5.1 million (recorded in 2024), while the average stood at $4.9 million.
  • In the last 5 years, Evolus' Share-based Compensation crashed by 39.50% in 2021 and then skyrocketed by 86.10% in 2022.
  • Quarterly analysis of 5 years shows Evolus' Share-based Compensation stood at $2.6 million in 2021, then dropped by 8.95% to $2.4 million in 2022, then soared by 82.30% to $4.4 million in 2023, then surged by 40.35% to $6.2 million in 2024, then fell by 1.63% to $5.1 million in 2025.
  • Its Share-based Compensation stands at $5.1 million for Q3 2025, versus $4.5 million for Q2 2025 and $5.9 million for Q1 2025.